Alzheimer’s Drug Discovery Foundation Funds ALS Biopharma

ALS Biopharma has received a grant from ADDF to support their chaperone drug development program. ALS Biopharma is developing brain-penetrant Hsp70 inducers that clear a spectrum of toxic misfolded proteins known to be found in ALS and AD patients.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail